Two disputatious tribes are currently arguing about the outlook for UK tech: call them the Fullies and the Empties, depending on whether they view a glass as half-full or half-empty.

Read Jennifer Doudna’s tribute to Demis Hassabis here. Demis Hassabis learned he had won the 2024 Nobel Prize in Chemistry ...

European AI investment is thriving, with venture capital funding up 55 per cent in Q1 2025 compared to the same period last year.

i Niazi, SK, Quantum mechanics paradox in protein structure prediction: Intrinsically linked to sequence yet independent of it, Computational and Structural Biotechnology Reports, Volume 2, 2025, ...

Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...

NVIDIA will be the first industry partner to adopt SynthID, a Google DeepMind AI technology that embeds digital watermarks ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

Source: DeepLearning.AI. According to Demis Hassabis, Isomorphic Labs has successfully raised $600 million to enhance their AI-driven initiatives in drug discovery. This significant funding is poised ...

and is a significant step forward towards our mission of one day solving all disease with the help of AI," said Demis Hassabis, founder and CEO of Isomorphic Labs, according to the New York Post.

In the memo, Google DeepMind CEO Demis Hassabis said the move will “sharpen our focus on the next evolution of the Gemini app,” reports Semafor. Google spokesperson Alex Joseph confirmed ...